42
|
233
|
7pg9F |
Human 20s proteasome |
39
|
196
|
7pg9K |
Human 20s proteasome |
47
|
200
|
7pg9L |
Human 20s proteasome |
54
|
247
|
7pg9C |
Human 20s proteasome |
52
|
239
|
7pg9G |
Human 20s proteasome |
45
|
229
|
7pg9B |
Human 20s proteasome |
54
|
233
|
7pg9E |
Human 20s proteasome |
38
|
204
|
7pg9J |
Human 20s proteasome |
50
|
232
|
7pg9D |
Human 20s proteasome |
46
|
202
|
7pg9H |
Human 20s proteasome |
44
|
212
|
7pg9M |
Human 20s proteasome |
50
|
212
|
7pg9N |
Human 20s proteasome |
51
|
239
|
7pg9A |
Human 20s proteasome |
49
|
220
|
7pg9I |
Human 20s proteasome |
37
|
196
|
7v5mK |
20s+monoub-cyclinb1-nt (s2) |
46
|
220
|
7v5mI |
20s+monoub-cyclinb1-nt (s2) |
40
|
233
|
7v5mF |
20s+monoub-cyclinb1-nt (s2) |
46
|
229
|
7v5mB |
20s+monoub-cyclinb1-nt (s2) |
47
|
200
|
7v5mL |
20s+monoub-cyclinb1-nt (s2) |
51
|
247
|
7v5mC |
20s+monoub-cyclinb1-nt (s2) |
51
|
233
|
7v5mE |
20s+monoub-cyclinb1-nt (s2) |
46
|
212
|
7v5mN |
20s+monoub-cyclinb1-nt (s2) |
48
|
240
|
7v5mA |
20s+monoub-cyclinb1-nt (s2) |
46
|
232
|
7v5mD |
20s+monoub-cyclinb1-nt (s2) |
38
|
212
|
7v5mM |
20s+monoub-cyclinb1-nt (s2) |
44
|
202
|
7v5mH |
20s+monoub-cyclinb1-nt (s2) |
50
|
239
|
7v5mG |
20s+monoub-cyclinb1-nt (s2) |
40
|
204
|
7v5mJ |
20s+monoub-cyclinb1-nt (s2) |
58
|
196
|
7aweK |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
66
|
229
|
7aweB |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
54
|
204
|
7aweJ |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
75
|
247
|
7aweC |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
64
|
213
|
7aweM |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
68
|
203
|
7aweL |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
56
|
223
|
7aweI |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
69
|
234
|
7aweD |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
68
|
240
|
7aweA |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
65
|
242
|
7aweG |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
41
|
197
|
7drwT |
Bovine 20s immunoproteasome in complex with two human pa28alpha-beta activators |
77
|
231
|
7drwH |
Bovine 20s immunoproteasome in complex with two human pa28alpha-beta activators |
49
|
216
|
7dr6K |
Pa28alpha-beta in complex with immunoproteasome |
72
|
246
|
7dr6B |
Pa28alpha-beta in complex with immunoproteasome |
53
|
232
|
7drwD |
Bovine 20s immunoproteasome in complex with two human pa28alpha-beta activators |
54
|
216
|
7drwV |
Bovine 20s immunoproteasome in complex with two human pa28alpha-beta activators |
45
|
213
|
7drwU |
Bovine 20s immunoproteasome in complex with two human pa28alpha-beta activators |
51
|
226
|
7drwB |
Bovine 20s immunoproteasome in complex with two human pa28alpha-beta activators |
45
|
201
|
7dr62 |
Pa28alpha-beta in complex with immunoproteasome |
53
|
240
|
7dr6R |
Pa28alpha-beta in complex with immunoproteasome |
47
|
213
|
7dr6J |
Pa28alpha-beta in complex with immunoproteasome |
50
|
235
|
7dr6Q |
Pa28alpha-beta in complex with immunoproteasome |